Worries About Discontinuing Buprenorphine Treatment: Scale Development and Clinical Correlates.

ABSTRACT:

Background and objectives

Despite the benefits of maintenance buprenorphine treatment for opioid use disorder (OUD), many individuals report an interest in discontinuing the medication, while also expressing worries about tapering. The purpose of this study was to develop a measure of worries about buprenorphine discontinuation ("Off Bupe") and determine the demographic and clinical characteristics associated with these worries.

Methods

Between May 2017 and May 2018, we surveyed adults in an outpatient primary care buprenorphine program (n = 138). Reliability and validity of the Off Bupe measure were examined.

Results

Participants averaged 39 years of age, 54% were male, average duration of buprenorphine was 189 weeks and 85.5% reported eventually wanting to discontin

SUBMITTER: Stein MD 

PROVIDER: S-EPMC6591066 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature